AzTrials
AzTrials

Regional Blood FlowDunhill01NCT01734616

Dysfunction of Nutritive Blood Flow as a Determinant of Anabolic Resistance in Older People

A study testing Old Exercise, Old Acute Cocoa and Old 7 Day Cocoa in people with Regional Blood Flow, run by University of Nottingham at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

With age, muscles tend to waste at 0.5-1% per year, so that an 80 year old may have only 70% of the muscle possessed at 50. Muscle loss makes it harder to carry out tasks that require strength, keep the body balanced and continue activity for a prolonged period, which together may contribute to a loss of independence… Read more about this study

Who is it for?
Ages 18 to 75 years, men onlyHealthy volunteers can take part
Conditions the study is for
Regional Blood Flow
What is being tested?
Old Exercise, Old Acute Cocoa and Old 7 Day Cocoa
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteUnited Kingdom
Study dates
Sep 2009to Aug 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • Men only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy volunteers aged 18-28 or 65-75

Who cannot join

  • Overt muscle wasting i.e. muscle mass is more than 1 standard deviation below normal muscle or FFM for age
  • A BMI < 24 or > 28 kg•m2.
  • Active cardiovascular disease: uncontrolled hypertension (BP > 160/100), angina, heart failure (class III/IV), arrhythmia, right to left cardiac shunt or recent cardiac event
  • Individuals taking beta-adrenergic blocking agents.
  • Cerebrovascular disease: previous stroke, aneurysm (large vessel or intracranial).
  • Respiratory disease including pulmonary hypertension, COPD, asthma or an FEV1 less than 1.5 l.
Show all 14Show fewer
  • Metabolic disease: hyper and hypo parathyroidism, untreated hyper and hypothyroidism, Cushing's disease, types 1 or 2 diabetes.
  • Active inflammatory bowel disease, or renal disease,
  • Malignancy
  • Recent steroid treatment (within 6 mo), or hormone replacement therapy.
  • Clotting dysfunction
  • Musculoskeletal or neurological disorders.
  • Family history of early (<55y) death from cardiovascular disease
  • Known sensitivity to Definity or methacholine

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Clinical Physiology Laboratory, Graduate Entry Medical School, University of Nottingham, Royal Derby Hospital

    Derby, Derbyshire, DE22 3DT

Other trials in United Kingdom

About this study

With age, muscles tend to waste at 0.5-1% per year, so that an 80 year old may have only 70% of the muscle possessed at 50. Muscle loss makes it harder to carry out tasks that require strength, keep the body balanced and continue activity for a prolonged period, which together may contribute to a loss of independence and an increased risk of falls. The cause of some of this muscle loss with ageing appears to be a reduction in muscle building in response to food. The known decreased limb blood flow in ageing muscle may go some way to explain this as there may be less nutrient delivery to the muscles. The investigators want to test if the known decrease in limb blood flow with age is matched with a decrease in the proportion of blood being delivered directly to the muscles, rather than fat and connective tissue. If so the investigators expect to see an improvement in the ability of muscles to maintain themselves via better capture of amino acids into protein. The investigators also want to test if 20 weeks resistance exercise training or drinking a cocktail of mixture of high flavanol cocoa (which can increase blood flow) and vitamin C can improve limb blood flow to older muscles and help reduce muscle wasting.

Read the detailed description

By 2020, 20% of the UK population will be over 65 y. Muscle mass is a strong predictor of healthy ageing and longevity. Basal limb blood flow decreases with advancing age; reduced limb perfusion may contribute to sarcopenia, the undesirable loss of muscle mass that accompanies advancing age. The investigators previous work has shown that there are deficits in the mechanisms of muscle protein synthesis in older people, but why these exist and how they may be countered is still unknown. After normal feeding, increased amino acid availability (stimulating muscle protein synthesis) and insulin availability (inhibiting muscle protein breakdown) do have good effects in the muscle of older people but not to the same extent as in the young; the investigators call this "anabolic resistance". The investigators have recently shown that leg blood flow in elderly people is lower than in the young at rest in the basal state and also at rest up to 2.5 hours after food and or food + exercise. The matching of blood flow and metabolism is advantageous for skeletal muscle, in marrying demands for oxygen and nutrients to their delivery; the reduced limb perfusion in the older people may contribute to an inability to maintain muscle mass with ageing. The investigators have recently shown that resistance training markedly improves leg blood flow responses in elderly persons. They believe a major benefit of resistance exercise is to increase endothelium dependent vasodilation in response to feeding and moderate exercise, but this needs to be proved. It is becoming recognised that it is not only "bulk" limb blood flow that may be important in muscle nutrient uptake but that so called 'nutritive' blood flow is an important determinant. Recent work suggests that bulk limb flow is not only partitioned between skin, bone and muscle but even within muscle is partitioned between 'nutritive' and 'non-nutritive'. The nutritive route has intimate contact with muscle cells while the non-nutritive route acts as a vascular shunt and is thought to be, at least in part, via vessels that nourish fat and connective tissue cells. Nutritive flow may be the component of flow which is most susceptible to dysfunction5 (e.g. with type 2 diabetes and obesity) but may also be the most susceptible to improvement by accustomed exercise and possibly nutraceutical treatment.

The investigators will test the hypotheses: (1) muscle nutritive blood flow is a determinant of protein balance, with pharmacologically induced vasodilation acutely stimulating muscle synthesis and reducing breakdown, (2) low nutritive flow in elderly people contributes to anabolic resistance and can be ameliorated by resistance training or nutraceutical flow enhancers.

The investigators wish to study 50 healthy volunteer subjects (not NHS patients) as follows: 18-28 y men (10) and 65-75 y men (40) of comparable body mass index (24-28 kg•m2) all of whom are sedentary and normally undertake no customary resistance training. The investigators have data suggesting sexual dimorphism of anabolic responses to feeding in older subjects so will restrict studies to men only. After obtaining written consent, all subjects will undergo a medical examination, activity questionnaire and DEXA scan. Ten elderly men will undergo a single acute study. In addition the investigators will study 10 young men under the same conditions. Ten more elderly men will undergo an acute study after 20 weeks of supervised whole-body resistance training, as is current practice at a gym site in Derby. Ten more elderly men will undergo a single acute study in which they are given, in addition to the standard acute study protocol 3 drinks of high flavanol cocoa and 3 x 500 mg of vitamin C. If a positive acute effect of the drinks is observed the final ten elderly men will undergo an acute study after a week of ingesting 3 high flavanol cocoa + 1000 mg of vitamin C per day. To optimise details of study conditions the investigators will also study up to 10 normal healthy volunteers 18-75 y simply with the CEUS contrast agent and methacholine infusions, without any blood sampling or biopsies.

Subjects fasted overnight will receive primed constant intravenous (antecubital vein) infusions of stable isotope labelled amino acids for the duration of the study and blood samples will be taken from an arterial cannula and two femoral venous cannulae at regular intervals to quantify tracer enrichment and measure glucose uptake and insulin. In the first phase of the study, subjects' bulk femoral artery blood flow will be measured at 50, 70, 90 and 110 min by Doppler Ultrasound (USS). Nutritive blood flow will be measured in a defined area of the quadriceps in the control leg by Contrast Enhanced Ultrasound (CEUS) using the Phillips iU22 at 110 min. This involves a single intravenous administration of SonoVue® contrast agent. At 120 min the second phase of the study will begin with a dextrose and mixed amino acid intravenous infusion (antecubital vein) for the remainder of the study. Methacholine chloride (Provocholine®; Methapharm Inc.) in NaCl (0.9%, prepared by QMC pharmacy)will be infused (at 2-12 µg/min) into one femoral artery to double femoral artery flow at 150 min. Bulk femoral artery flow will again be measured (Doppler Ultrasound), this time in both legs at 170, 190, 210 and 230 min. Nutritive flow will be measured for a second time, in both legs by CEUS at 230 min. Four muscle biopsies (150-300 mg) of vastus lateralis will be taken according to the protocol and snap-frozen in liquid nitrogen.

The end points will be i. muscle protein synthesis, ii. muscle protein breakdown, iii. bulk femoral blood flow and iv. nutritive femoral blood flow in subjects of different ages or following different exercise or nutraceutical intervention. A power calculation suggests that this study will need 10 subjects per group to detect (with α of 0.05 and β of 0.85) a 25 % difference between groups in biological variables, results the investigators have been able to achieve for similar work in the past.

Being tested
Old Exercise, Old Acute Cocoa, Old 7 Day Cocoa
Keywords
Microvascular, Muscle, Nutrition, Exercise, Ageing
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Old ExerciseBehavioural

  • Old Acute CocoaDietary supplement

  • Old 7 Day CocoaDietary supplement

Study groups in NCT01734616
Study groupRoleWhat they receive
YoungNo interventionYoung subjects to be controlled to older individuals with interventions
OldNo interventionOlder individuals to compare to young and other older intervention groups
Old ExerciseExperimentalOlder individuals studied after an intervention of 20 weeks fully-supervised resistance exercise training
Receives: Behavioral: Old Exercise
Old Acute CocoaExperimentalOlder individuals studied with the addition of cocoa flavanols during their acute study
Receives: Dietary Supplement: Old Acute Cocoa
Old 7 Day CocoaExperimentalOlder individuals studied after 7 day supplementation of cocoa flavanols
Receives: Dietary Supplement: Old 7 Day Cocoa

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Microvascular blood volume in response to feeding

    The final study participant was completed and all microvascular blood volume data analysed by August 2012. This outcome measure is applicable to all arms of this study and refers to responsiveness to a 2 hour feed protocol.

    Measured: September 2009 - August 2012

Secondary outcomes (1)
  1. Muscle protein metabolism in response to feeding

    Muscle protein metabolism (synthesis and breakdown) in response to feeding in young and older individuals and in older individuals after exercise or nutraceutical intervention. This outcome measure could only be assessed after all studies were completed to ensure standardization of mass-spectrometry measurements between the groups.

    Measured: January - October 2012

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Nov 2012 (estimated)
  2. Study startSep 2009
  3. Primary completionAug 2012
  4. Study completionAug 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01734616
Sponsor's protocol ID
F/3/2009
Acronym
Dunhill01
Status last verified
Nov 2012
First submitted
21 Nov 2012
Last updated
28 Nov 2012
Results posted
No
Data monitoring committee
No

Publications

  • Phillips B, Williams J, Atherton P, Smith K, Hildebrandt W, Rankin D, Greenhaff P, Macdonald I, Rennie MJ. Resistance exercise training improves age-related declines in leg vascular conductance and rejuvenates acute leg blood flow responses to feeding and exercise. J Appl Physiol (1985). 2012 Feb;112(3):347-53. doi: 10.1152/japplphysiol.01031.2011. Epub 2011 Oct 13.

    PubMed 21998269

Questions about this trial

What is this clinical trial studying?

A study testing Old Exercise, Old Acute Cocoa and Old 7 Day Cocoa in people with Regional Blood Flow, run by University of Nottingham at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Nov 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Microvascular blood volume in response to feeding (time frame: September 2009 - August 2012). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01734616, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Nov 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in